Another Tylenol Recall Underway Due To Moldy Smell
Johnson & Johnson is recalling another lot of Tylenol because of a moldy odor.
J&J said it was voluntarily recalling another lot of the product. It has already recalled tens of millions of bottles of Tylenol and other consumer medicines in the past year because of complaints of a musty or moldy odor in the product.
The company said almost 128,000 bottles of Tylenol have been recalled in this latest action. J&J is facing a U.S. congressional probe of quality control lapses that have led to its numerous recent recalls of Tylenol, painkiller Motrin and allergy treatment Benadryl.
“This voluntary action is being taken as a precaution and the risk of adverse medical events is remote,” the diversified healthcare company said in a release.
A J&J spokeswoman said the product was the adult Tylenol eight-hour caplets sold in 50-count bottles in the U.S. and Puerto Rico.
She said the recall made in March was for the products made at a factory in Fort Washington, Pennsylvania.
J&J shut down the McNeil plant the next month and is upgrading the facility to correct quality control lapses the U.S. Food and Drug Administration inspectors discovered.
The FDA said that thick dust, grime and contaminated ingredients at the Fort Washington plant led to the shut down. J&J plans to reopen the plant next year.
The plant helped to make up about $650 million worth of products, which is 1 percent of total annual company sales.
On January 15, J&J recalled 53 million bottles of Tylenol, Motrin and antacid Rolaids because of musty or moldy odors. The smell was traced to a chemical called 2,4,6-tribromoanisole present in wooden pallets that transport and store product packaging materials.
On the Net: